This message was sent to ##Email##
|
|
|
|
|
| |
AST
There are several opportunities to advance legislation with a direct impact on transplantation. You can make your voice heard by reaching out to your local representatives to encourage their support and sponsorship of the Comprehensive Immunosuppressive Drug Coverage for Kidney patients Act of 2016 and the Living Donor Protection Act. Visit the AST website to learn more about these legislative items and help raise awareness through an urgent request for grassroots support.
Contact your three Members of Congress and urge them to cosponsor & pass these important transplant community legislative initiatives. The preferred grassroots method to advance legislation is to personally make contact with your two U.S. Senators and U.S. House Representative. Information on identifying and accessing contact information for your representatives is available on the AST website for your convenience.
AST
Tuesday's U.S. elections were closely watched here and around the world. November 8, 2016 will go down in the record books as one of the biggest upsets in modern political history. Defying all national projections and political polling, Donald Trump was elected the 45th President of the United States. On Capitol Hill, Republicans maintained their majorities in the U.S. Senate and House of Representatives. To learn more about how the election results may impact legislation that the AST is supporting and the anticipated impacts on healthcare in general, please take a few moments to read the new AST Washington Round-up - November 2016 Election Results Update.
AST
The nomination submission website for the 2017 AST Board of Directors is now open and accepting applications. AST recognizes the importance of electing strong leaders and encourages nominations from qualified AST members. Detailed information and the nomination criteria can be found here. All nominations must be submitted by Friday, November 18, 2016.
 |
|
Sanofi Genzyme supports physicians in solid organ transplant through:
• Ongoing support of major professional societies
• Medical education
• Fellows conferences
• Professional education for community physician groups
We are investing in the present and future of transplantation
|
|
AST
The American Society of Transplantation (AST) is pleased to announce its call for nominations for 2017 Achievement Awards. Each year, the AST sponsors a variety of Achievement Awards in recognition of its members' accomplishments and contributions to the field of transplantation. All nominations must be submitted by Friday, November 18, 2016. To view award categories and eligibility criteria, and to start your nomination, visit this link.
AST
You may have seen the recent AST news item related to heater-cooler devices that are putting open-heart surgery patients at risk. The CDC has updated its heater-cooler web page to provide frequently asked questions for hospitals regarding this issue. The CDC’s heater-cooler web page provides a number of resources that may be a helpful to you and your organization’s members. The page features links to CDC’s notification toolkit, press release, Health Alert Notification (HAN), and recent MMWR report. Additionally, this page offers important information for open-heart surgery patients. Please feel free to share this information with your colleagues and members.
Questions and Answers: Hospitals - Frequently Asked Questions for Hospitals Notifying Patients of Risk from Contaminated Heater-Cooler Devices Used During Cardiac Surgery
AST
Visit the AST Member Spotlight section of the website to find out what transplantation means to Dr. Maricar Malinis and why she chose to work in this exciting field!
Interested in being featured in the AST Member Spotlight? Please contact rmassi@myAST.org for more information.
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
November 15, 2016 2 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/t3
Registration Now Open for CEOT 2017
AST
The theme of improving long-term outcomes is extending into AST's 2017 Cutting Edge of Transplantation (CEOT) meeting. We hope you will join us for "One Transplant for Life: Many Pathways to Success." February 23-25 in Phoenix, Arizona, being held at the beautiful Arizona Biltmore. Throughout the conference, individual sessions will focus on specific topic areas regarding donor organ survival including barriers to therapeutic innovation, enhanced measures of quality and value, tolerance, recipient candidacy and post-transplant infections, as well as policy topics such as the use of marginal organs. Abstract submission is now open, with submissions accepted through Nov. 18, 2016.
Young Innovator Award Travel Grants
AST will award a limited number of Young Innovator Award (YIA) travel grants to the highest scoring abstracts submitted by emerging professionals in transplantation. If awarded a YIA travel grant, the recipient must register for and attend the Cutting Edge of Transplantation and present the abstract. The Planning Committee will award travel grants in the amount of $500 each.
Medicine, Health Care and Philosophy
A provocative question has emerged since the Supreme Court of Canada’s decision on assisted dying: Should Canadians who request, and are granted, an assisted death be considered a legitimate source of transplantable organs? A related question is addressed in this paper: is controlled organ donation after assisted death (cDAD) more or less ethically-problematic than standard, controlled organ donation after circulatory determination of death (cDCDD)?
READ MORE
American Journal of Transplantation
In this paper, we have reviewed the literature and report on kidney donors that are currently used at relatively low rates. Kidneys from donors with acute kidney injury (AKI) seem to have outcomes equivalent to those from donors without AKI, provided one can rule out significant cortical necrosis. Kidneys from donors with preexisting diabetes or hypertension may have marginally lower aggregate survival but still provide patients with a significant benefit over remaining on the wait list.
READ MORE
American Journal of Transplantation
This article is a review of the salient points and a future prospective based on the 2014 Organ Procurement and Transplantation Network (OPTN)/Scientific Registry of Transplant Recipients (SRTR) liver donation and transplantation data report recently published by the American Journal of Transplantation.
READ MORE
American Journal of Transplantation
This article is a review of the salient points and a future prospective based on the 2014 Organ Procurement and Transplantation Network (OPTN)/Scientific Registry of Transplant Recipients (SRTR) liver donation and transplantation data report recently published by the American Journal of Transplantation.
READ MORE
American Journal of Transplantation
The role of mammalian target of rapamycin (mTOR) inhibitors in de novo immunosuppression after lung transplantation is not well defined. We compared Everolimus versus mycophenolate mofetil in an investigator-initiated single-center trial in Hannover, Germany. A total of 190 patients were randomly assigned 1:1 on day 28 posttransplantation to mycophenolate mofetil (MMF) or Everolimus combined with cyclosporine A (CsA) and steroids.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
